RU2005125062A - Комбинированный препарат от головокружения - Google Patents

Комбинированный препарат от головокружения Download PDF

Info

Publication number
RU2005125062A
RU2005125062A RU2005125062/15A RU2005125062A RU2005125062A RU 2005125062 A RU2005125062 A RU 2005125062A RU 2005125062/15 A RU2005125062/15 A RU 2005125062/15A RU 2005125062 A RU2005125062 A RU 2005125062A RU 2005125062 A RU2005125062 A RU 2005125062A
Authority
RU
Russia
Prior art keywords
combination drug
combination
cinnarizine
dimenhydrinate
dizziness
Prior art date
Application number
RU2005125062/15A
Other languages
English (en)
Inventor
Хельга ШЛЕЕНХАЙН (DE)
Хельга ШЛЕЕНХАЙН
Original Assignee
ХЕННИГ АРЦНАЙМИТТЕЛЬ ГМБХ энд КО. КГ (DE)
ХЕННИГ АРЦНАЙМИТТЕЛЬ ГМБХ энд КО. КГ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ХЕННИГ АРЦНАЙМИТТЕЛЬ ГМБХ энд КО. КГ (DE), ХЕННИГ АРЦНАЙМИТТЕЛЬ ГМБХ энд КО. КГ filed Critical ХЕННИГ АРЦНАЙМИТТЕЛЬ ГМБХ энд КО. КГ (DE)
Publication of RU2005125062A publication Critical patent/RU2005125062A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (3)

1. Применение циннаризина и дименгидрината или их физиологически совместимых солей в комбинации для лечения головокружения любого происхождения.
2. Применение циннаризина и дименгидрината или их физиологически совместимых солей в комбинации для изготовления лекарственных средств с целью лечения головокружения любого происхождения.
3. Применение циннаризина и дименгидрината или их физиологически совместимых солей в комбинации наряду с фармацевтически совместимыми вспомогательными и/или дополнительными веществами для изготовления лекарственных средств с целью лечения головокружения любого происхождения.
RU2005125062/15A 2003-01-15 2004-01-14 Комбинированный препарат от головокружения RU2005125062A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10301981A DE10301981A1 (de) 2003-01-15 2003-01-15 Kombinationspräparat gegen Schwindel
DE10301981.2 2003-01-15

Publications (1)

Publication Number Publication Date
RU2005125062A true RU2005125062A (ru) 2006-01-27

Family

ID=32602769

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005125062/15A RU2005125062A (ru) 2003-01-15 2004-01-14 Комбинированный препарат от головокружения

Country Status (11)

Country Link
US (3) US20060135533A1 (ru)
EP (2) EP1622622A2 (ru)
JP (2) JP2006515610A (ru)
KR (1) KR20050092106A (ru)
CN (1) CN1738626A (ru)
BR (1) BRPI0406746A (ru)
CA (1) CA2511948A1 (ru)
DE (1) DE10301981A1 (ru)
PL (1) PL378180A1 (ru)
RU (1) RU2005125062A (ru)
WO (1) WO2004064843A2 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301981A1 (de) * 2003-01-15 2004-07-29 Hennig Arzneimittel Gmbh & Co. Kg Kombinationspräparat gegen Schwindel
DE102005014142B4 (de) * 2005-03-23 2006-11-09 Hennig Arzneimittel Gmbh & Co. Kg Pelletförmige Retardzubereitung gegen Schwindel
DE102005014141B4 (de) * 2005-03-23 2006-12-21 Hennig Arzneimittel Gmbh & Co. Kg Tablettenförmige Retardzubereitung gegen Schwindel
WO2011024029A1 (en) * 2009-08-24 2011-03-03 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Fast disintegrating dosage forms of cinnarizine and dimenhydrinate combination
CN109170773A (zh) * 2018-10-09 2019-01-11 河南科技大学 一种宇航员用防眩晕功能食品的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2499058A (en) 1950-02-28 B-haloxantfflne salts of diarylalkyl
US2882271A (en) 1959-04-14 Xcixcxh
US2534813A (en) 1950-01-21 1950-12-19 Searle & Co 8-haloxanthine salts of cyclic-aminoalkyl benzohydryl ethers and the production thereof
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
DE10301981A1 (de) * 2003-01-15 2004-07-29 Hennig Arzneimittel Gmbh & Co. Kg Kombinationspräparat gegen Schwindel
DE102005014142B4 (de) * 2005-03-23 2006-11-09 Hennig Arzneimittel Gmbh & Co. Kg Pelletförmige Retardzubereitung gegen Schwindel
DE102005014141B4 (de) * 2005-03-23 2006-12-21 Hennig Arzneimittel Gmbh & Co. Kg Tablettenförmige Retardzubereitung gegen Schwindel

Also Published As

Publication number Publication date
BRPI0406746A (pt) 2005-12-20
PL378180A1 (pl) 2006-03-06
EP1622622A2 (de) 2006-02-08
US20120157475A1 (en) 2012-06-21
WO2004064843A3 (de) 2004-12-23
EP2174690A1 (de) 2010-04-14
JP2006515610A (ja) 2006-06-01
US20060135533A1 (en) 2006-06-22
US20090137602A1 (en) 2009-05-28
DE10301981A1 (de) 2004-07-29
KR20050092106A (ko) 2005-09-20
CN1738626A (zh) 2006-02-22
WO2004064843A2 (de) 2004-08-05
CA2511948A1 (en) 2004-08-05
JP2011140502A (ja) 2011-07-21

Similar Documents

Publication Publication Date Title
DE60121301D1 (de) Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
EE200300295A (et) Kinuklidiinkarbamaadi derivaat, selle saamine ja kasutamine ravimi valmistamiseks, mis on ette nähtud respiratoorsete, kuseelundite või mao-soolte haiguste ravimiseks, ning seda sisaldav ravimkompositsioon
ATE426635T1 (de) Arzneimittelverabreichung
EP1848418A4 (en) USE OF NORDIHYDROGUAIARETIC ACID DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT VIRAL AND MICROBIAL CANCERS AND INFECTIONS
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
JP2005530735A5 (ru)
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
JP2005511619A5 (ru)
DE502004010644D1 (de) Geschmacksstoffhaltige arzneimittelformulierungen mit verbesserten pharmazeutischen eigenschaften
IL187575A (en) Benzofuranyl derivatives ,pharmaceutical formulations comprising the same and use thereof in the preparation of medicaments for the treatment of 5-ht6-receptor related disorders
RU2005125062A (ru) Комбинированный препарат от головокружения
ITMI20021866A1 (it) Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee.
ES2188513T3 (es) Utilizacion de desoxipeganina para el tratamiento de la drogodependencia.
DE602004022515D1 (de) Fenofibrate tablett und verfahren zur herstellung
HK1031101A1 (en) Drug for external use in suffer from traumatic injury, beriberoid disease, lumbago, with its making and magistral medicines
DE602006016168D1 (de) 1,3,5-triazepin-dionen zur Behandlung von Malaria
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
DE602007007320D1 (de) Pharmazeutische zusammensetzung mit tetrahydrolipstatin
ATE499945T1 (de) Pharmazeutische zusammensetzung zur behandlung von invasiver lungenaspergillose
ATE456573T1 (de) Nmb0928-protein und dessen verwendung in pharmazeutischen formulierungen
IL163431A (en) 1 - phenyl - 2 - heteroaryl - substituted benzimidazole derivatives and the use thereof for producing drugs used in the treatment of immunological diseases
FR2864089B1 (fr) Derives carboxy-reduits de la chondroitine sulfate, leur preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
IL162769A0 (en) Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
CL2004000633A1 (es) Compuestos copolimeros, composicion farmaceutica que los contiene y procedimiento de preparacion, utiles en el tratamiento de enfermedades metabolicas oseas.